K Fusi B Cream is a topical pharmaceutical formulation containing Betamethasone 0.1% w/w, a potent corticosteroid, combined with Fusidic Acid 2% w/w, a bacteriostatic antibiotic. This combination is indicated for the treatment of inflammatory dermatoses complicated by bacterial infections or at risk of secondary bacterial infection. Betamethasone exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and itching. Fusidic Acid acts by inhibiting bacterial protein synthesis, particularly effective against Gram-positive organisms such as Staphylococcus aureus, including beta-lactamase-producing strains. K Fusi B Cream is commonly prescribed for conditions such as infected eczema, impetiginized dermatitis, and other superficial bacterial skin infections with associated inflammation. The cream should be applied topically in a thin layer to the affected area once or twice daily, as directed by a healthcare professional. Treatment duration should be limited to the shortest possible period to minimize potential side effects associated with corticosteroids, such as skin atrophy or systemic absorption. Caution is advised in patients with hypersensitivity to any component, and use on extensive areas or broken skin should be avoided unless supervised by a physician.